Nuvalent
NUVL
NUVL was delisted on the 14th of July, 2026.
47 hedge funds and large institutions have $941M invested in Nuvalent in 2021 Q3 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
98.87% more ownership
Funds ownership: 0% → 98.87% (+99%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$561M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$186M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$99.5M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$47.8M |
| 5 |
Janus Henderson Group
London,
|
+$41.4M |
Top Sellers
NUVL Hedge Fund Activity: Q3 2021 in Review
47 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q3 2021, worth a combined $941M.
Buyers outnumbered sellers: 47 funds opened new NUVL positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $561M.
- 47 institutional investors held Nuvalent (NUVL) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $941M of Nuvalent stock for Q3 2021.
- 47 funds opened new Nuvalent positions in Q3 2021 and 0 closed out, a net change of +47 holders.
- The largest Nuvalent buyer in Q3 2021 was Deerfield Management, an estimated $561M added.
Based on aggregated 13F filings for Q3 2021.